Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kovaltry in Chinese Patients with Severe Hemophilia A
NCT04565236Phase 4Completed
- Sponsor
- Bayer
- Start
- Sep 2020
- Primary completion
- Mar 2024
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of damoctocog alfa pegol in hemophilia A, sponsored by Bayer. Started Sep 2020; status: completed.
02
Drugs
damoctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT04565236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04565236.